Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Baxter
Deloitte
Teva
Merck
Colorcon
Queensland Health
Cerilliant

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018104

« Back to Dashboard

NDA 018104 describes HYLOREL, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the HYLOREL profile page.

The generic ingredient in HYLOREL is guanadrel sulfate. There is one drug master file entry for this compound. Additional details are available on the guanadrel sulfate profile page.
Summary for 018104
Tradename:HYLOREL
Applicant:Pharmacia And Upjohn
Ingredient:guanadrel sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG
Approval Date:Dec 29, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Dec 29, 1982TE:RLD:No

Expired US Patents for NDA 018104

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn HYLOREL guanadrel sulfate TABLET;ORAL 018104-001 Dec 29, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn HYLOREL guanadrel sulfate TABLET;ORAL 018104-002 Dec 29, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
Cipla
UBS
Merck
Argus Health
Dow
McKinsey
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.